BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25173906)

  • 21. Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.
    Ueno S; Nakanishi A; Nishi K; Suzuki S; Terasaki H
    Doc Ophthalmol; 2015 Feb; 130(1):71-6. PubMed ID: 25391361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute macular neuroretinopathy--case report].
    Pojda-Wilczek D; Herba E
    Klin Oczna; 2005; 107(1-3):127-9. PubMed ID: 16052823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
    Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
    BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Angiography in Systemic Lupus Erythematosus-Induced Choroiditis.
    Lee KR; Peng LY; Iqbal TB; Subrayan V
    Ocul Immunol Inflamm; 2018; 26(8):1146-1149. PubMed ID: 28362518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of diffuse subretinal fibrosis uveitis with rituximab.
    Cornish KS; Kuffova L; Forrester JV
    Br J Ophthalmol; 2015 Feb; 99(2):153-4. PubMed ID: 24879811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients.
    Stanwyck LK; Moussa K; Chan W; Aitken PA; Sobrin L
    Ophthalmol Retina; 2019 Nov; 3(11):1007-1009. PubMed ID: 31420299
    [No Abstract]   [Full Text] [Related]  

  • 29. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
    Aronow ME; Adamus G; Abu-Asab M; Wang Y; Chan CC; Zakov ZN; Singh AD
    Surv Ophthalmol; 2012 Nov; 57(6):558-64. PubMed ID: 22784677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DIFFUSE LARGE B-CELL LYMPHOMA-ASSOCIATED-RETINOPATHY CHARACTERIZED BY MINIMAL MORPHOLOGIC CHANGES AND SEVERE FUNCTIONAL IMPAIRMENT.
    Moyal L; Zambrowski O; Thirkill C; Bottin C; Blanco R; Haioun C; Souied EH
    Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S2-S6. PubMed ID: 27571424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of reduced electroretinographic responses in thymoma-associated retinopathy: a case report and literature review.
    Mizobuchi K; Hayashi T; Katagiri S; Kim E; Ishiba Y; Watanabe S; Furukawa T; Nakano T
    Doc Ophthalmol; 2020 Oct; 141(2):195-204. PubMed ID: 32239315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alström syndrome--a case report and literature review.
    Karska-Basta I; Kubicka-Trzaska A; Filemonowicz-Skoczek A; Romanowska-Dixon B; Kobylarz J
    Klin Oczna; 2008; 110(4-6):188-92. PubMed ID: 18655459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.
    Tyni T; Kivelä T; Lappi M; Summanen P; Nikoskelainen E; Pihko H
    Ophthalmology; 1998 May; 105(5):810-24. PubMed ID: 9593380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
    Oporto Caroca JI; Oporto Caroca J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus.
    Damato E; Chilov M; Lee R; Singh A; Harper S; Dick A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):379-81. PubMed ID: 21970667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune retinopathy and antiretinal antibodies: a review.
    Grewal DS; Fishman GA; Jampol LM
    Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute exudative paraneoplastic polymorphous vitelliform maculopathy in five cases.
    Al-Dahmash SA; Shields CL; Bianciotto CG; Witkin AJ; Witkin SR; Shields JA
    Ophthalmic Surg Lasers Imaging; 2012; 43(5):366-73. PubMed ID: 22822903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unusual type of cancer-associated retinopathy in a patient with ovarian cancer.
    Yoon YH; Cho EH; Sohn J; Thirkill CE
    Korean J Ophthalmol; 1999 Jun; 13(1):43-8. PubMed ID: 10761396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute zonal occult outer retinopathy in a patient with graft-versus-host disease.
    Cheung MC; Nune GC; Hwang DG; Sutter EE; Duncan JL
    Am J Ophthalmol; 2004 Dec; 138(6):1058-60. PubMed ID: 15629309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.